Lexicon Pharmaceuticals

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Lexicon Pharmaceuticals ( LXRX) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. This stock, rated D sell by TheStreet Ratings, is trading up 9.4% to $1.27 in recent trading.

Today's Range: $1.22-$1.30

52-Week Range: $0.81-$2.17

Volume: 575,000

Three-Month Average Volume: 607,792

Shares of LXRX are spiking notably higher today after the company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than DPP-4 inhibitor did on a stand-alone basis.

From a technical standpoint, LXRX is quickly approaching a breakout trade if this stock can manage to sustain a high-volume move and close above some past overhead resistance levels at $1.32 to $1.44.

Look for a move and close above those levels on volume that's near or above 607,792 shares. If we get that action, then look for LXRX to challenge its August high of $1.85.

If you liked this article you might like

Not All That Glitters Is Gold in World of Financial Technology

Cybersecurity, Robotics Stocks Hold Promise for Value Investors

How to Find 100-to-1 Moonshots

Financial Technology Purveyors, Banks Can Peacefully Co-Exist

Vasco Data Security International (VDSI) Is Today's Strong On High Volume Stock